Cabaletta Bio Inc (CABA)
12.75
-0.12
(-0.93%)
USD |
NASDAQ |
May 07, 16:00
12.75
0.00 (0.00%)
After-Hours: 19:03
Cabaletta Bio Market Cap: 615.08M for May 7, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| May 06, 2024 | 620.87M |
| May 03, 2024 | 597.71M |
| May 02, 2024 | 607.84M |
| May 01, 2024 | 598.68M |
| April 30, 2024 | 513.53M |
| April 29, 2024 | 505.57M |
| April 26, 2024 | 531.14M |
| April 25, 2024 | 587.58M |
| April 24, 2024 | 625.21M |
| April 23, 2024 | 642.58M |
| April 22, 2024 | 642.58M |
| April 19, 2024 | 643.54M |
| April 18, 2024 | 673.94M |
| April 17, 2024 | 730.86M |
| April 16, 2024 | 785.86M |
| April 15, 2024 | 780.55M |
| April 12, 2024 | 821.55M |
| April 11, 2024 | 864.01M |
| April 10, 2024 | 861.60M |
| April 09, 2024 | 907.91M |
| April 08, 2024 | 870.28M |
| April 05, 2024 | 819.14M |
| April 04, 2024 | 777.17M |
| April 03, 2024 | 793.09M |
| April 02, 2024 | 795.50M |
| Date | Value |
|---|---|
| April 01, 2024 | 811.42M |
| March 28, 2024 | 823.00M |
| March 27, 2024 | 827.34M |
| March 26, 2024 | 818.18M |
| March 25, 2024 | 809.98M |
| March 22, 2024 | 836.99M |
| March 21, 2024 | 846.16M |
| March 20, 2024 | 874.14M |
| March 19, 2024 | 868.35M |
| March 18, 2024 | 867.38M |
| March 15, 2024 | 904.05M |
| March 14, 2024 | 879.34M |
| March 13, 2024 | 938.71M |
| March 12, 2024 | 960.51M |
| March 11, 2024 | 945.20M |
| March 08, 2024 | 1.042B |
| March 07, 2024 | 1.036B |
| March 06, 2024 | 1.046B |
| March 05, 2024 | 1.005B |
| March 04, 2024 | 1.019B |
| March 01, 2024 | 1.112B |
| February 29, 2024 | 1.061B |
| February 28, 2024 | 1.069B |
| February 27, 2024 | 1.128B |
| February 26, 2024 | 1.092B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
18.26M
Minimum
Sep 23 2022
1.177B
Maximum
Feb 08 2024
321.02M
Average
274.13M
Median
Market Cap Benchmarks
| Editas Medicine Inc | 465.11M |
| Regeneron Pharmaceuticals Inc | 106.91B |
| Vertex Pharmaceuticals Inc | 105.96B |
| FibroGen Inc | 134.82M |
| Deciphera Pharmaceuticals Inc | 2.050B |
Market Cap Related Metrics
| Price to Book Value | 2.604 |
| Price | 12.75 |
| Earnings Yield | -13.02% |